Cargando…
The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis
INTRODUCTION: Atopic dermatitis (AD) is featured by pruritus, which causes diminished quality of life. Little clinical data exists concerning the use, efficacy and side effects of UVA1 phototherapy in AD patients. AIM: To determine the effectiveness of medium-dose UVA1 phototherapy in AD treatment....
Autores principales: | Malinowska, Karolina, Woźniacka, Anna, Bogaczewicz, Jarosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874877/ https://www.ncbi.nlm.nih.gov/pubmed/33603617 http://dx.doi.org/10.5114/ada.2019.88465 |
Ejemplares similares
-
Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis
por: Bogaczewicz, Jarosław, et al.
Publicado: (2016) -
SCORAD Reflects the Duration of Atopic Dermatitis Lesions
por: Čelakovská, Jarmila, et al.
Publicado: (2013) -
Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy
por: Breuckmann, Frank, et al.
Publicado: (2002) -
The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis
por: Celakovská, Jarmilă, et al.
Publicado: (2016) -
Erythrocyte zinc level in patients with atopic dermatitis and its relation to SCORAD index
por: Karabacak, Ercan, et al.
Publicado: (2016)